Literature DB >> 32160103

Informing Patients About Expected Outcomes: The Efficacy-Effectiveness Gap.

Arnoud J Templeton1, Christopher M Booth2, Ian F Tannock3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32160103     DOI： 10.1200/JCO.19.02035

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  8 in total

1.  Real-World Safety and Efficacy Outcomes with Abiraterone Acetate Plus Prednisone or Prednisolone as the First- or Second-Line Treatment for Metastatic Castration-Resistant Prostate Cancer: Data from the Prostate Cancer Registry.

Authors:  Anders Bjartell; Nicolaas Lumen; Pablo Maroto; Thomas Paiss; Francisco Gomez-Veiga; Alison Birtle; Gero Kramer; Ewa Kalinka; Dominique Spaëth; Susan Feyerabend; Vsevolod Matveev; Florence Lefresne; Martin Lukac; Robert Wapenaar; Luis Costa; Simon Chowdhury
Journal:  Target Oncol       Date:  2021-04-07       Impact factor: 4.493

2.  Pragmatic trials with prespecified subgroups: what oncologists can learn from COVID-19.

Authors:  Rahul Banerjee; Vinay Prasad
Journal:  Nat Rev Clin Oncol       Date:  2021-01       Impact factor: 66.675

Review 3.  Management of patients with multiple myeloma beyond the clinical-trial setting: understanding the balance between efficacy, safety and tolerability, and quality of life.

Authors:  Evangelos Terpos; Joseph Mikhael; Roman Hajek; Ajai Chari; Sonja Zweegman; Hans C Lee; María-Victoria Mateos; Alessandra Larocca; Karthik Ramasamy; Martin Kaiser; Gordon Cook; Katja C Weisel; Caitlin L Costello; Jennifer Elliott; Antonio Palumbo; Saad Z Usmani
Journal:  Blood Cancer J       Date:  2021-02-18       Impact factor: 11.037

4.  Effectiveness and implementation of SHared decision-making supported by OUTcome information among patients with breast cancer, stroke and advanced kidney disease: SHOUT study protocol of multiple interrupted time series.

Authors:  Jet W Ankersmid; Noel Engels; Janine C M Prick; Mariska Quirina Nikita Hackert; Steven Teerenstra; Sabine Siesling; Constance H C Drossaert; Luc J A Strobbe; Yvonne E A van Riet; René M A van den Dorpel; Willem Jan W Bos; Paul B van der Nat; Renske M van den Berg-Vos; Sander M van Schaik; Mirjam M Garvelink; Philip J van der Wees; Cornelia F van Uden-Kraan
Journal:  BMJ Open       Date:  2022-08-01       Impact factor: 3.006

5.  Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Real-World Data from an Academic Central and Eastern European Center.

Authors:  Marija Ivanović; Lea Knez; Ana Herzog; Mile Kovačević; Tanja Cufer
Journal:  Oncologist       Date:  2021-08-02

6.  Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey.

Authors:  Marie-France Savard; Mashari Jemaan Alzahrani; Deanna Saunders; Lynn Chang; Angel Arnaout; Terry L Ng; Muriel Brackstone; Lisa Vandermeer; Tina Hsu; Ari Ali Awan; Katherine Cole; Gail Larocque; Mark Clemons
Journal:  Curr Oncol       Date:  2021-12-08       Impact factor: 3.677

7.  Prognostic value of patient-reported quality of life for survival in oesophagogastric cancer: analysis from the population-based POCOP study.

Authors:  J J van Kleef; W P M Dijksterhuis; H G van den Boorn; M Prins; R H A Verhoeven; S S Gisbertz; M Slingerland; N Haj Mohammad; G-J Creemers; K J Neelis; J Heisterkamp; C Rosman; J P Ruurda; E A Kouwenhoven; L V van de Poll-Franse; M G H van Oijen; M A G Sprangers; H W M van Laarhoven
Journal:  Gastric Cancer       Date:  2021-07-12       Impact factor: 7.701

8.  Real-world outcomes associated with new cancer medicines approved by the Food and Drug Administration and European Medicines Agency: A retrospective cohort study.

Authors:  Jemma M Boyle; Gemma Hegarty; Christopher Frampton; Elizabeth Harvey-Jones; Joanna Dodkins; Katharina Beyer; Gincy George; Richard Sullivan; Christopher Booth; Ajay Aggarwal
Journal:  Eur J Cancer       Date:  2021-08-06       Impact factor: 9.162
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.